Kirsten rat sarcoma (KRAS)
Showing 1 - 25 of 1,687
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +14 more
- ELI-002 7P
- (no location specified)
Feb 3, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)
Terminated
- Metastatic Colorectal Cancer (CRC)
- BI 1701963
- Camptosar®
-
Shanghai, ChinaShanghai East Hospital, Tongji University China
Apr 19, 2022
AdvAdvanced Solid Tumors, Kirsten Rat Sarcoma Trial in Shanghai (GH35 Tablet)
Recruiting
- AdvAdvanced Solid Tumors
- Kirsten Rat Sarcoma
- GH35 Tablet
-
Shanghai, Shanghai, China
- +1 more
Dec 16, 2021
Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986466
- +2 more
-
Birmingham, Alabama
- +24 more
Aug 29, 2023
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Pancreatic Cancer, Circulating Tumor DNA, KRAS Mutation-Related Tumors Trial (Blood samples)
Completed
- Pancreatic Cancer
- +2 more
- Blood samples
- (no location specified)
Sep 17, 2020
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)
Completed
- Infiltrating Urothelial Carcinoma
- KRAS Gene Mutation
-
Bordeaux, France
- +16 more
Mar 4, 2021
Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)
Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)
Not yet recruiting
- Non-Small-Cell Lung Carcinoma
- +2 more
- Liquid biopsy
- (no location specified)
Jan 24, 2023
Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +4 more
- (no location specified)
Oct 23, 2023
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)
Active, not recruiting
- Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
- Selumetinib
- +3 more
-
Aurora, Colorado
- +196 more
Dec 22, 2022
NSCLC Trial in Worldwide (Sotorasib)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Birmingham, Alabama
- +65 more
Nov 29, 2022
Tissue Microarrays (TMAs) Construction in Lung Cancer Samples
Completed
- Lung Cancer
-
Athens, GreeceOCEBER
Mar 13, 2019
Radiomics for prEdiction of lunG cAncer biologY
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- PET/CT
-
Poitiers, FranceCHU Poitiers
Apr 5, 2023
Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)
Completed
- Metastatic Colorectal Cancer
-
Stockton, California
- +151 more
Sep 8, 2022
Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)
Recruiting
- Advanced Solid Tumors
- GEC255 tablets
-
Chengdu, Sichuan, ChinaChina West Hospital
Mar 14, 2023
HER3 Expression in Non-Small Cell Lung Cancer
Recruiting
- Non-small Cell Lung Cancer
- Archival tissue specimen and immunohistochemistry staining
-
Miami, Florida
- +1 more
Mar 14, 2023
NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +5 more
- (no location specified)
Aug 17, 2023